OPTI1 Feb 2020 20:40
07 January 2019
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has entered into an exclusive manufacturing and supply agreement with Zeon Lifesciences Ltd ("Zeon"). The agreement grants Zeon an exclusive license to manufacture and supply OptiBiotix's SlimBiome® weight management technology in India, in return for 50% of the profit
I would imagine the deal with Agropur would have to be of a very similar arrangement.